36C26121Q1015.docx

Presolicitation Notice Presolicitation Notice

GENERAL INFORMATION

SET-ASIDE

VA Sierra Pacific Network (VISN 21)

VA Southern Nevada Health Care System

6900 N Pecos Road

North Las Vegas NV

COUNTRY

CONTACT INFORMATION

VA Sierra Pacific Network (VISN 21) VA Pacific Islands Health Care System 459 Patterson Rd Honolulu HI 96819-1522

POINT OF CONTACT*

Contract Specialist Moneque Rodriguez Moneque.Rodriguez@va.gov 808-539-1304

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

PRE-SOLICITATION NOTICE OF INTENT TO SOLE SOURCE

Department of Veterans Affairs (VA) Network Contracting Office 21 (NCO 21) hereby gives notice of the Government’s intent to establish a single award fixed price indefinite delivery/ indefinite quantity (IDIQ) contract for a period of performance of 5 years with Diasorin Inc. to acquire Diasorin Liaison XL Analyzer Cost Per Test (CPT) services to run procalcitonin, vitamin D, Quantiferon TB, and covid tests. This IDIQ will be used as a simplified method of filling anticipated repetitive needs at the VA Southern Nevada Health Care System: 6900 N Pecos Road, North Las Vegas, NV 89086.

Determination of this single source procurement is in accordance with Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 U.S.C. § 1901 and as implemented by FAR 13.106-1(b)(2). It is the Government’s belief that the proposed candidate is the only provider of Diasorin Liaison XL Analyzer (CPRR) services that can meet the agency’s needs. The applicable North American Industry Classification System (NAICS) code is 334516 (Analytical Laboratory Instrument Manufacturing) and the Federal Supply Code (FSC) is 6640 (Laboratory Equipment and Supplies). The Liaison XL Analyzer currently exists on site, and the supplies that are needed are highly specialized, FDA‐approved assays capable of being processed using CLIA technology and those fitting of all of laboratory’s requirements. Diasorin’s Liaison XL is the only open access, continuous feed instrument capable of detecting latent Tuberculosis using an FDA‐cleared assay.

All responsible sources may submit a quotation, capability statement, and supporting evidence furnished in sufficient detail to demonstrate the ability to comply with the above requirement by August 06, 2021 at 3PM Hawaii Time to moneque.rodriguez@va.gov to be considered. After this time if no alternative sources are found, a sole source solicitation will be posted to this announcement.

After consideration, the Government will determine whether to proceed with the sole source acquisition. A Justification and Approval (J&A) will be executed by the Head of Contracting Activity (HCA) for the contract and will be posted to SAM.gov as required by the Federal Acquisition Regulation (FAR) 13.501 (a)(1)(iii).

Presolicitation Notice